Amarin Corp Plc (AMRN)

[sts66]

Maybe they think nobody could possible be so incompetent as to have the greatest CVD drug of the last 25 yrs but have no ability to sell it, so there must be another problem holding down growth, and they want to know what it is and if they can improve sales. This is not just any random drug, it has some baggage holding it down - ties to "fish oil" CVOT failures, multiple claims that R-IT was affected by MO, patent loss in the US, and a history of patient non-compliance (they stop in 6 months). IOW it's not a plug'n'play drug for reps.